RETRACTABLE TECHNOLOGIES INC
RVPNYSE AMERICANTrading Snapshot
- Day Range
- $0.69 – $0.71
- 52-Week Range
- $0.60 – $1.14
- Volume
- $3.02B
- Avg Volume
- $3.65B
- Shares Outstanding
- 29.9M
- Next Earnings
- Nov 22, 2026
Fundamentals Snapshot
- Annual Revenue
- $38M
- Last Q Revenue
- $7M
- P/E Ratio
- -5.8
- P/S Ratio
- 0.6x
- EPS (TTM)
- $-0.11
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +0.0%
Why Investors Own RVP
- ✓High-growth profile — revenue up -9.6% YoY with expanding US Equity exposure.
- ✓Healthy economics — 37% gross margin and 20% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
RETRACTABLE TECHNOLOGIES INC
RVP
StockOtter · stockotter.spaceAbout RETRACTABLE TECHNOLOGIES INC
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps. They also offer small diameter tube adapters, blood collection tube holders, allergy trays, and IV safety catheters. Further offerings feature VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. Distribution of these products occurs through a combination of general and specialized distributors, international partners, and a dedicated direct sales network. Founded in 1994, the company's main operations are headquartered in Little Elm, Texas.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Retractable Technologies, Inc. Supports Senator Blackburn's ONSHORE Manufacturing Act
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announces its support for Senator Marsha Blackburn's ONSHORE Manufacturing Act, legislation aimed at strengthening d
RVP Stock Gains Post Q2 Earnings Despite Fall in Sales & Unit Volumes
Retractable's second-quarter 2026 sales weaken on EasyPoint order timing, while investment gains drive earnings and tariffs remain a key sourcing challenge.
Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.2 million for the second quarter of 2026 and an operating loss of $5.1 million for the period, as comp
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series II